Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-
Adolescent
Adult
Animals
Child
Child, Preschool
Familial Mediterranean Fever
/ blood
Female
Genotype
Humans
Infant
Male
Mutation
/ genetics
Myalgia
/ blood
Pericarditis
/ genetics
Prognosis
Receptors, Tumor Necrosis Factor, Type I
/ genetics
Retrospective Studies
Tumor Necrosis Factor-alpha
/ blood
Young Adult
Journal
Mediators of inflammation
ISSN: 1466-1861
Titre abrégé: Mediators Inflamm
Pays: United States
ID NLM: 9209001
Informations de publication
Date de publication:
2020
2020
Historique:
received:
08
04
2020
accepted:
19
06
2020
entrez:
25
8
2020
pubmed:
25
8
2020
medline:
17
7
2021
Statut:
epublish
Résumé
This study explores demographic, clinical, and therapeutic features of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a cohort of 80 patients recruited from 19 Italian referral Centers. Patients' data were collected retrospectively and then analyzed according to age groups (disease onset before or after 16 years) and genotype (high penetrance (HP) and low penetrance (LP)
Identifiants
pubmed: 32831641
doi: 10.1155/2020/8562485
pmc: PMC7428902
doi:
Substances chimiques
Receptors, Tumor Necrosis Factor, Type I
0
TNFRSF1A protein, human
0
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8562485Informations de copyright
Copyright © 2020 Carla Gaggiano et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Medicine (Baltimore). 2002 Sep;81(5):349-68
pubmed: 12352631
J Med Genet. 2018 Aug;55(8):530-537
pubmed: 29599418
Semin Arthritis Rheum. 2014 Jun;43(6):818-23
pubmed: 24393624
Ann Rheum Dis. 2006 Sep;65(9):1158-62
pubmed: 16569687
Orphanet J Rare Dis. 2017 Oct 18;12(1):167
pubmed: 29047407
Ann Rheum Dis. 2011 Feb;70(2):309-14
pubmed: 21081528
Ann Med. 2011 Aug;43(5):341-6
pubmed: 21284530
Ann Rheum Dis. 2015 May;74(5):799-805
pubmed: 25637003
Ann Rheum Dis. 2019 Aug;78(8):1025-1032
pubmed: 31018962
Rheumatology (Oxford). 2009 Aug;48(8):987-91
pubmed: 19541728
Ann Rheum Dis. 2006 Nov;65(11):1427-32
pubmed: 16707534
Autoimmun Rev. 2016 Jan;15(1):9-15
pubmed: 26299986
Autoimmun Rev. 2012 Nov;12(1):38-43
pubmed: 22884554
Front Immunol. 2017 Mar 27;8:299
pubmed: 28396659
Clin Rheumatol. 2014 Sep;33(9):1197-207
pubmed: 24935411
Ann Rheum Dis. 2012 Oct;71(10):1599-605
pubmed: 22661645
Ann Rheum Dis. 2014 Dec;73(12):2160-7
pubmed: 23965844
Genes Immun. 2004 Jun;5(4):289-93
pubmed: 15071491
Int J Immunopathol Pharmacol. 2011 Jul-Sep;24(3):695-702
pubmed: 21978701
Ann Rheum Dis. 2017 May;76(5):821-830
pubmed: 27811147
Arthritis Care Res (Hoboken). 2017 Apr;69(4):578-586
pubmed: 27723279
Arthritis Rheum. 2002 Aug;46(8):2181-8
pubmed: 12209523
Semin Arthritis Rheum. 2016 Apr;45(5):633-7
pubmed: 26620106
Cell. 1999 Apr 2;97(1):133-44
pubmed: 10199409
Reumatol Clin. 2019 Aug 14;:
pubmed: 31422021
Reumatismo. 2013 Jun 12;65(2):55-62
pubmed: 23877409
Arthritis Rheum. 2013 Apr;65(4):1116-21
pubmed: 23280696
Arthritis Rheum. 2011 Apr;63(4):1141-50
pubmed: 21225694
Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):701-7
pubmed: 20943039
Am J Hum Genet. 2001 Aug;69(2):301-14
pubmed: 11443543
Ann Rheum Dis. 2019 Oct;78(10):1405-1411
pubmed: 31278138